The DOI matches its Crossref record; 333 of the 333 references it cites were found in a registry or an index.
Bayesian methods in health technology assessment: a review.
Open accessAbstract
BACKGROUND: Bayesian methods may be defined as the explicit quantitative use of external evidence in the design, monitoring, analysis, interpretation and reporting of a health technology assessment. In outline, the methods involve formal combination through the use of Bayes's theorem of: 1. a prior distribution or belief about the value of a quantity of interest (for example, a treatment effect) based on evidence not derived from the study under analysis, with 2. a summary of the information concerning the same quantity available from the data collected in the study (known as the likelihood), to yield 3. an updated or posterior distribution of the quantity of interest. These methods thus directly address the question of how new evidence should change what we currently believe. They extend naturally into making predictions, synthesising evidence from multiple sources, and designing studies: in addition, if we are willing to quantify the value of different consequences as a 'loss function', Bayesian methods extend into a full decision-theoretic approach to study design, monitoring and eventual policy decision-making. Nonetheless, Bayesian methods are a controversial topic in that they may involve the explicit use of subjective judgements in what is conventionally supposed to be a rigorous scientific exercise. OBJECTIVES: This report is intended to provide: 1. a brief review of the essential ideas of Bayesian analysis 2. a full structured review of applications of Bayesian methods to randomised controlled trials, observational studies, and the synthesis of evidence, in a form which should be reasonably straightforward to update 3. a critical commentary on similarities and differences between Bayesian and conventional approaches 4. criteria for assessing the reporting of a Bayesian analysis 5. a comprehensive list of published 'three-star' examples, in which a proper prior distribution has been used for the quantity of primary interest 6. tutorial case studies of a variety of types 7. recommendations on how Bayesian methods and approaches may be assimilated into health technology assessments in a variety of contexts and by a variety of participants in the research process. METHODS: The BIDS ISI database was searched using the terms 'Bayes' or 'Bayesian'. This yielded almost 4000 papers published in the period 1990-98. All resultant abstracts were reviewed for relevance to health technology assessment; about 250 were so identified, and used as the basis for forward and backward searches. In addition EMBASE and MEDLINE databases were searched, along with websites of prominent authors, and available personal collections of references, finally yielding nearly 500 relevant references. A comprehensive review of all references describing use of 'proper' Bayesian methods in health technology assessment (those which update an informative prior distribution through the use of Bayes's theorem) has been attempted, and around 30 such papers are reported in structured form. There has been very limited use of proper Bayesian methods in practice, and relevant studies appear to be relatively easily identified. RESULTS: Bayesian methods in the health technology assessment context 1. Different contexts may demand different statistical approaches. Prior opinions are most valuable when the assessment forms part of a series of similar studies. A decision-theoretic approach may be appropriate where the consequences of a study are reasonably predictable. 2. The prior distribution is important and not unique, and so a range of options should be examined in a sensitivity analysis. Bayesian methods are best seen as a transformation from initial to final opinion, rather than providing a single 'correct' inference. 3. The use of a prior is based on judgement, and hence a degree of subjectivity cannot be avoided. However, subjective priors tend to show predictable biases, and archetypal priors may be useful for identifying a reasonable range of prior opinion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–333 of 333
Mega-trials and management of acute myocardial infarction
Woods, K. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91440-4 · Cited by 72
Interim analysis in clinical trials
Armitage, P. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100613 · Cited by 72
Monitoring Accumulating Data in a Clinical Trial
Berry, D. A. (1989) · Biometrics · doi:10.2307/2531771 · Cited by 70
The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions
Matchar, D. B., Samsa, G. P., Matthews, J. R., Ancukiewicz, M., Parmigiani, G., Hasselblad, V., Wolf, P. A., D’Agostino, R. B., & Lipscomb, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00054 · Cited by 68
On choosing the number of interim analyses in clinical trials
McPherson, K. (1982) · Statistics in Medicine · doi:10.1002/sim.4780010105 · Cited by 67
Magnesium in Acute MI: Timing Is Critical
Antman, E. M. (1995) · Circulation · doi:10.1161/01.cir.92.9.2367 · Cited by 66
A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials
Whitehead, A. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19971230)16:24<2773::aid-sim761>3.0.co;2-q · Cited by 66
Stopping guidelines vs stopping rules: a practitioner's point of view
DeMets, D. L. (1984) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928408828833 · Cited by 66
Li, Z., & Begg, C. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476892 · Cited by 65
An introduction to the Bayesian analysis of clinical trials
Lewis, R., & Wears, R. L. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80119-2 · Cited by 64
Hierarchical models for multicentre binary response studies
Skene, A. M., & Wakefield, J. C. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090808 · Cited by 64
A Brief History of Statistics in Three and One-Half Chapters: A Review Essay
Fienberg, S. E. (1992) · Statistical Science · doi:10.1214/ss/1177011360 · Cited by 63
Kendall's Advanced Theory of Statistics: Vol. 2B, Bayesian Inference.
Dickey, J., & O’Hagan, A. (1996) · Journal of the American Statistical Association · doi:10.2307/2291686 · Cited by 63
Progress Toward a More Ethical Method for Clinical Trials
Kadane, J. B. (1986) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/11.4.385 · Cited by 63
Bayesian subset analysis in a colorectal cancer clinical trial
Dixon, D. O., & Simon, R. M. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110104 · Cited by 61
MTW, Berry, D. A., & Stangl, D. K. (1996) · Journal of the American Statistical Association · doi:10.2307/2291615 · Cited by 61
Accrual strategies for phase I trials with delayed patient outcome
Thall, P. F., Lee, J. J., Tseng, C., & Estey, E. H. (1999) · Statistics in Medicine · Cited by 60
Equipoise and the Ethics of Clinical Research
Freedman, B. (2017) · Routledge eBooks · doi:10.4324/9781315244426-17 · Cited by 60
Kadane, J. B. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00072-0 · Cited by 59
Projection from previous studies: A Bayesian and frequentist compromise
Brown, B. W., Herson, J., Atkinson, E. N., & Rozell, M. E. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90023-7 · Cited by 59
Assessing Whether to Perform a Confirmatory Randomized Clinical Trial
Parmar, M., Ungerleider, R. S., & Simon, R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.22.1645 · Cited by 59
On the Allocation of Treatments in Sequential Medical Trials
Bather, J. A. (1985) · International Statistical Review · doi:10.2307/1402870 · Cited by 59
Using empirical bayes methods in biopharmaceutical research
Louis, T. A. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100604 · Cited by 58
Optimal Bayesian Randomization
Berry, S. M., & Kadane, J. B. (1997) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/1467-9868.00098 · Cited by 57
Comparative calibration without a gold standard
Lü, Y., Ye, K., Mathur, A. K., Hui, S. L., Fuerst, T. P., & Genant, H. K. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970830)16:16<1817::aid-sim621>3.0.co;2-n · Cited by 57
Comparative Statistical Inference (2nd ed.).
Brockett, P. L., & Barnett, V. (1983) · Journal of the American Statistical Association · doi:10.2307/2288682 · Cited by 57
Approaches to Monitoring Clinical Trials
Fleming, T. R., & Watelet, L. F. M. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.3.188 · Cited by 55
New designs for the selection of treatments to be tested in randomized clinical trials
Simon, R. M., Thall, P. F., & Ellenberg, S. S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130506 · Cited by 53
Bayesian meta-analysis, with application to studies of ETS and lung cancer
Tweedie, R. L., Scott, D. J., Biggerstaff, B. J., & Mengersen, K. L. (1996) · Lung Cancer · doi:10.1016/s0169-5002(96)90222-6 · Cited by 53
Helping doctors to draw appropriate inferences from the analysis of medical studies
Burton, P. R. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131702 · Cited by 53
Bayesian Statistical Inference for Psychological Research
Edwards, W., Lindman, H. R., & Savage, L. J. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-0919-5_34 · Cited by 52
Detsky, A. S. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90118-3 · Cited by 51
Early Stopping of a Clinical Trial When There is Evidence of No Treatment Benefit
Dignam, J. J., Bryant, J., Wieand, H. S., Fisher, B., & Wolmark, N. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00041-5 · Cited by 50
Assessing Uncertainty in Cost-Effectiveness Analyses
Parmigiani, G., Samsa, G., Ancukiewicz, M., et al. (1997) · Medical Decision Making · doi:10.1177/0272989x9701700404 · Cited by 50
Approximate Bayesian inference for random effects meta-analysis
Abrams, K. R., & Sansó, B. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980130)17:2<201::aid-sim736>3.0.co;2-9 · Cited by 50
Statistical Analysis of Medical Data: New Developments
MTW, Everitt, B. J., & Dunn, G. D. (2000) · Journal of the American Statistical Association · doi:10.2307/2669588 · Cited by 48
Empirical Bayes estimates of subgroup effects in clinical trials
DAVIS, C. E., & Leffingwell, D. P. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90030-6 · Cited by 48
On Bayesian Methods for Bioequivalence
Selwyn, M. R., & Hall, N. (1984) · Biometrics · doi:10.2307/2531161 · Cited by 48
BAYESIAN PREDICTIVE APPROACH FOR INFERENCE ABOUT PROPORTIONS
Lecoutre, B., Derzko, G., & Grouin, J. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140924 · Cited by 46
Application of bayesian statistics to decision making during a clinical trial
Freedman, L. S., & Spiegelhalter, D. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110105 · Cited by 45
Frei, A., Cottier, C., Wunderlich, P., & Ludin, E. N. (1987) · Stroke · doi:10.1161/01.str.18.2.373 · Cited by 45
Reporting bayesian analyses of clinical trials
Hughes, M. D. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121802 · Cited by 45
Hierarchical Models for Combining Information and for Meta-Analyses
Morris, C. N., & Normand, S. T. (1992) · Oxford University Press eBooks · doi:10.1093/oso/9780198522669.003.0018 · Cited by 45
Prediction and decision making using Bayesian hierarchical models
Stangl, D. K. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142002 · Cited by 44
Small clinical trials: Are they all bad?
Matthews, J. N. S. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140204 · Cited by 44
What is the prior probability of a proposed new treatment being superior to established treatments?
Chalmers, I. (1997) · BMJ · doi:10.1136/bmj.314.7073.74a · Cited by 44
Craig, B. Α., Fryback, D. G., Klein, R., & Klein, B. E. K. (1999) · Statistics in Medicine · Cited by 42
A Bayesian strategy for screening cancer treatments prior to phase II clinical evaluation.
Thall, P., & Estey, E. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121303 · Cited by 42
The Cost-Benefit of a Randomized Trial to a Health Care Organization
Hornberger, J. C., & Eghtesady, P. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00098-6 · Cited by 42
Raghunathan, T. E., & Siscovick, D. S. (1996) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2986092 · Cited by 42
Cross design synthesis: a new strategy for studying medical outcomes?
(1992) · The Lancet · doi:10.1016/0140-6736(92)92822-w · Cited by 42
A Bayesian approach to the interpretation of subgroup results in clinical trials
Donner, A. P. (1982) · Journal of Chronic Diseases · doi:10.1016/0021-9681(82)90057-1 · Cited by 41
Decision analysis and bioequivalence trials
Lindley, D. V. (1998) · Statistical Science · doi:10.1214/ss/1028905932 · Cited by 41
A case for Bayesianism in clinical trials (with discussion)
Berry, D. A. (1993) · Statistics in Medicine · Cited by 40
Charts for the early stopping of pilot studies.
Mehta, C. R., & Cain, K. C. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.6.676 · Cited by 38
Comments on Bayesian and frequentist analysis and interpretation of clinical trials
Fisher, L. D. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00043-8 · Cited by 38
Bayesian analyses of two-treatment crossover studies
Grieve, A. P. (1994) · Statistical Methods in Medical Research · doi:10.1177/096228029400300406 · Cited by 37
Formal measurement of clinical uncertainty: prelude to a trial in perinatal medicine
Lilford, R. J. (1994) · BMJ · doi:10.1136/bmj.308.6921.111 · Cited by 36
The case for frequentism in clinical trials
Whitehead, J. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121506 · Cited by 36
Assessing Placebo Response Using Bayesian Hierarchical Survival Models
Stangl, D. K., & Greenhouse, J. B. (1998) · Lifetime Data Analysis · doi:10.1023/a:1009644308160 · Cited by 35
Implications for trials in progress of publication of positive results
FLETCHER, A. E., Spiegelhalter, D. J., Staessen, J. A., Thijs, L., & Bulpitt, C. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91762-b · Cited by 35
A unified method for monitoring and analysing controlled trials
Grossman, J., Parmar, M., Spiegelhalter, D. J., & Freedman, L. S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131804 · Cited by 34
Estimating treatment effects in clinical crossover trials
Grieve, A. P., & Senn, S. J. (1998) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543409808835233 · Cited by 34
Carlin, B. P., Chaloner, K. M., Church, T. R., Louis, T. A., & Matts, J. P. (1993) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348470 · Cited by 34
Decision-Analytic Determination of Study Size
Thompson, M. S. (1981) · Medical Decision Making · doi:10.1177/0272989x8100100206 · Cited by 33
Simes, R. J. (1986) · Statistics in Medicine · doi:10.1002/sim.4780050505 · Cited by 33
The delta and epsilon errors in the assessment of cancer clinical trials.
Staquet, M. J., Rozencweig, M., Hoff, D. D. V., & Muggia, F. M. (1979) · PubMed · Cited by 32
A Bayesian group sequential design for a multiple arm randomized clinical trial
Rosner, G. L., & Berry, D. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140405 · Cited by 32
Evaluating the NHS research and development programme: will the programme give value for money?
Buxton, M. J., & Hanney, S. (1998) · Journal of the Royal Society of Medicine · doi:10.1177/014107689809135s02 · Cited by 31
Some practical aspects of the interim monitoring of clinical trials
Simon, R. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131315 · Cited by 31
Bayesian analysis of case‐control studies
Marshall, R. J. (1988) · Statistics in Medicine · doi:10.1002/sim.4780071203 · Cited by 31
Decision Analysis in the Selection, Design and Application of Clinical and Health Services Research
Lilford, R. J., & Royston, G. (1998) · Journal of Health Services Research & Policy · doi:10.1177/135581969800300307 · Cited by 30
Decision analysis and Bayesian methods in clinical trials
Berry, D. A. (1995) · Cancer treatment and research · doi:10.1007/978-1-4615-2009-2_7 · Cited by 29
Cronin, K. A., Legler, J. M., & Etzioni, R. (1998) · Statistics in Medicine · Cited by 29
META-ANALYSIS: CURRENT ISSUES IN RESEARCH SYNTHESIS
Olkin, I. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960630)15:12<1263::aid-sim305>3.0.co;2-k · Cited by 29
Using databases to evaluate therapy
Hlatky, M. A. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100415 · Cited by 29
Sensitivity of Bayes Inference with Data-Dependent Stopping Rules
Rosenbaum, P. R., & Rubin, D. B. (1984) · The American Statistician · doi:10.1080/00031305.1984.10483176 · Cited by 29
Domiciliary thrombolysis by general practitioners.
Pocock, S., & Spiegelhalter, D. J. (1992) · BMJ · doi:10.1136/bmj.305.6860.1015 · Cited by 28
Exploratory thoughts on clinical trials with utilities
Tan, S. B., & Smith, A. F. M. (1998) · Statistics in Medicine · Cited by 27
Passive smoking in the workplace: classical and Bayesian meta-analyses
Biggerstaff, B. J., Tweedie, R. L., & Mengersen, K. L. (1994) · International Archives of Occupational and Environmental Health · doi:10.1007/bf00454366 · Cited by 27
Empirical Bayes Methods in Clinical Trials Meta‐Analysis
Stijnen, T., & van Houwelingen, H. C. (1990) · Biometrical Journal · doi:10.1002/bimj.4710320316 · Cited by 27
Design and analysis of trials of salvage therapy in acute myelogenous leukemia
Estey, E. H., Thall, P. F., & David, C. L. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051054 · Cited by 26
Spiegelhalter, D. J., Harris, N. L., Bull, K., & Franklin, R. C. G. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476765 · Cited by 25
Simple Bayesian analysis in clinical trials: A tutorial
Abrams, K. R., Ashby, D., & Errington, D. (1994) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)90032-9 · Cited by 25
Inference and decision in clinical trials
Armitage, P. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90033-4 · Cited by 25
Extending a Bayesian analysis of the two‐period crossover to allow for baseline measurements
Grieve, A. P. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130903 · Cited by 25
Sample sizes for event rate equivalence trials using prior information
Gould, A. L. (1993) · Statistics in Medicine · doi:10.1002/sim.4780122105 · Cited by 25
Meta‐analysis for dose—response models
DuMouchel, W. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140524 · Cited by 24
Disease mapping using empirical bayes and bayes methods on mortality statistics in the Netherlands
Heisterkamp, S. H., Doornbos, G., & Gankema, M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121915 · Cited by 22
Problems of multiplicity in clinical trials
Simon, R. M. (1994) · Journal of Statistical Planning and Inference · doi:10.1016/0378-3758(94)90197-x · Cited by 21
Bayesian data monitoring in clinical trials
Fayers, P. M., Ashby, D., & Parmar, M. (1997) · UCL Discovery (University College London) · Cited by 21
Data monitoring committees and problems of lower-than-expected accrual or event rates
Korn, E. L., & Simon, R. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00088-8 · Cited by 20
Statistical Tools for Subset Analysis in Clinical Trials
Simon, R. M. (1988) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-83419-6_7 · Cited by 19
A Sample-Size-Optimal Bayesian Procedure for Sequential Pharmaceutical Trials
Cressie, N., & Biele, J. (1994) · Biometrics · doi:10.2307/2532784 · Cited by 19
Monitoring of a pilot toxicity study with two adverse outcomes
Etzioni, R., & PEPE, M. S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780132203 · Cited by 19
Robustness considerations in Bayesian analysis
Gustafson, P. (1996) · Statistical Methods in Medical Research · doi:10.1177/096228029600500403 · Cited by 19
Bayesian Methods in Phase III Trials
Berry, D. A. (1991) · Drug Information Journal · doi:10.1177/009286159102500306 · Cited by 19
Tunis, S., Sheinhait, I. A., Schmid, C. H., Bishop, D. J., & Ross, S. D. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80098-7 · Cited by 19
Magnesium and myocardial infarction
Egger, M., Smith, G. D., Herzog, W. R., Atar, D., Galloe, A. M., Graudal, N. A., Toussaint, B., Trylesinski, A., Horner, S. M., Montgomery, H., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92175-x · Cited by 19
Henderson, W. G., MORITZ, T. E., Goldman, S. M., Copeland, J. G., & Sethi, G. K. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00071-2 · Cited by 18
Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs
Dominici, F., Parmigiani, G., Wolpert, R. L., & Hasselblad, V. (1999) · Journal of the American Statistical Association · doi:10.2307/2669674 · Cited by 18
An application of bayesian analysis to medical follow‐up data
Achcar, J. A., Brookmeyer, R., & Hunter, W. G. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040411 · Cited by 17
Meta-analysis and the synthesis of evidence
Abrams, K. R., & Jones, D. R. H. (1995) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/12.3-4.297 · Cited by 17
Chelimsky, E., Silberman, G., & Droitcour, J. A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90253-d · Cited by 17
A Bayesian Framework for Intent-to-Treat Analysis with Missing Data
KLEINMAN, K. P., Ibrahim, J. G., & Laird, N. M. (1998) · Biometrics · doi:10.2307/2534013 · Cited by 16
Emerson, S. S. (1995) · Biometrics · doi:10.2307/2533015 · Cited by 16
On some applications of bayesian methods in cancer clinical trials
Greenhouse, J. B. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110106 · Cited by 15
Early termination of a phase II clinical trial
Hilsenbeck, S. G. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90059-1 · Cited by 15
Spiegelhalter, D. J., & Freedman, L. S. (1988) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-83419-6_24 · Cited by 14
The Ethics of Randomised Controlled Trials: A Matter of Statistical Belief?
Hutton, J. L. (1996) · Health Care Analysis · doi:10.1007/bf02251209 · Cited by 14
Exact, conditional, and predictive power in planning clinical trials
Moussa, M. A. A. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90003-2 · Cited by 13
Interim Analyses in Clinical Research
Berry, D. A. (1987) · Cancer Investigation · doi:10.3109/07357908709032904 · Cited by 12
A decision‐theoretic evaluation of early stopping rules
Heitjan, D. F., Houts, P. S., & Harvey, H. A. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110511 · Cited by 12
A Bayesian Approach to the Analysis of Binary Crossover Data
Forster, J. J. (1994) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348932 · Cited by 10
Magnesium in acute myocardial infarction
WOODS, K. L., & Barnett, D. B. (1995) · BMJ · doi:10.1136/bmj.310.6995.1669c · Cited by 10
Stopping a clinical trial very early because of toxicity: Summarizing the evidence
Korn, E. L., Yu, K. F., & Miller, L. L. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90226-4 · Cited by 10
Extending a Bayesian Analysis of the Two-Period Crossover to Accommodate Missing Data
Grieve, A. P. (1995) · Biometrika · doi:10.1093/biomet/82.2.277 · Cited by 10
Combining Event Rates from Clinical Trials: Comparison of Bayesian and Classical Methods
Su, X. Y., & Po, A. L. W. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000504 · Cited by 9
Monitoring randomised controlled trials
Abrams, K. R. (1998) · BMJ · doi:10.1136/bmj.316.7139.1183 · Cited by 9
An Introduction to a Bayesian Method for Meta-Analysis: The Confidence Profile Method
Gelijns, A. C. (1990) · Cited by 9
Projection from previous studies
Korn, E. L. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90033-x · Cited by 8
Begg, C., DuMouchel, W., Harris, J., Dobson, A. P., Dear, K. B. G., Givens, G. H., Smith, D., & Tweedle, R. (1997) · Statistical Science · Cited by 8
A Physician-Based Architecture for the Construction and Use of Statistical Models
Shachter, R. D., & Lehmann, H. P. (1994) · Methods of Information in Medicine · doi:10.1055/s-0038-1635035 · Cited by 8
Bayesian approach for meta - analysis of controlled clinical trials
Rogatko, A. (1992) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929208830857 · Cited by 8
Using Historical Controls in Clinical Trials: Application to ECMO
Berry, D. A., & Hardwick, J. P. (1994) · Springer eBooks · doi:10.1007/978-1-4612-2618-5_12 · Cited by 6
Evaluation of bioequivalence studies
Grieve, A. P., & Pabst, G. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280080 · Cited by 4
Analysis of incomplete data under non-random mechanisms: bayesian inference
Pepple, P. A., & Choi, S. C. (1994) · Communications in Statistics - Simulation and Computation · doi:10.1080/03610919408813197 · Cited by 2
Bayesian interim analysis of randomised trials
Fayers, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63908-6 · Cited by 2
Bayesian interim analysis of randomised trials
Abrams, K. R., & Jones, D. R. H. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63909-8 · Cited by 2
Combining Information from Multiple Sources in the Analysis of a Non-Equivalent Control Group Design
Belin, T. R., Elashoff, R. M., Leung, K., Nisenbaum, R. A., Bastani, R., Nasseri, K., & Maxwell, A. E. (1995) · Lecture notes in statistics · doi:10.1007/978-1-4612-2546-1_5 · Cited by 1
Bayesian interim analysis of randomised trials
Gh, H. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63906-2 · Cited by 1
Meta-analysis: formulating, evaluating, combining, and reporting
Normand, S.-L. T. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990215)18:3<321::aid-sim28>3.0.co;2-p
Senn (1998) · doi:10.1002/(sici)1097-0258(19980815/30)17:15/16
Cited by
Mays, N., Pope, C., & Popay, J. (2005) · Journal of Health Services Research & Policy · doi:10.1258/1355819054308576 · Cited by 1,375
Dias, S., Sutton, A. J., Ades, A. E., & Welton, N. J. (2013) · Medical Decision Making · doi:10.1177/0272989x12458724 · Cited by 1,207
The JASP guidelines for conducting and reporting a Bayesian analysis
van Doorn, J., van den Bergh, D., Böhm, U., Dablander, F., Derks, K., Draws, T., Etz, A., Evans, N. J., Gronau, Q. F., Haaf, J. M., et al. (2021) · Psychonomic Bulletin & Review · doi:10.3758/s13423-020-01798-5 · Cited by 1,114
A catalogue of reporting guidelines for health research
Simera, I., Moher, D., Hoey, J., Schulz, K. F., & Altman, D. G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02234.x · Cited by 1,047
Adjusting for publication bias in the presence of heterogeneity
Terrin, N., Schmid, C. H., Lau, J., & Olkin, I. (2003) · Statistics in Medicine · doi:10.1002/sim.1461 · Cited by 809
Metadata
- Authors
- Spiegelhalter, Myles, Jones, & Abrams
- Venue
- Health Technology Assessment
- Published
- 2000
- Volume
- 4
- Issue
- 38
- Pages
- 1-130
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2161291623
- Cited by
- 358
- References
- 333
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- Health Technology Assessment Programme (93/50/05)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.